Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry-Reference-Cited by-同舟云学术

Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry

Published:2023-03 Issue: Volume:26 Page:100573
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Meegdes Marissa^ORCID,Geurts Sandra M.E.,Erdkamp Frans L.G.,Dercksen M. Wouter,Vriens Birgit E.P.J.,Aaldering Kirsten N.A.,Pepels Manon J.A.E.,van de Winkel Linda M.H.,Peters Natascha A.J.B.,Tol Jolien,Heijns Joan B.,van de Wouw Agnes J.,de Fallois Aude J.O.,van Kats Maartje A.C.E.,Tjan-Heijnen Vivianne C.G.

Publisher

Elsevier BV

Subject

Health Policy,Oncology,Internal Medicine

Reference27 articles.

1. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort;Gobbini;Eur J Cancer,2018

2. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer;Gennari;Ann Oncol,2021

3. Endocrine treatment and targeted therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: ASCO guideline update;Burstein;J Clin Oncol,2021

4. Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups;Johnston;npj Breast Cancer,2021

5. Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up;Rugo;Breast Cancer Res Treat,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synchronous Breast and Colorectal Malignant Tumors—A Systematic Review;Life;2024-08-13

2. EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe;European Journal of Cancer;2024-08

3. Locoregional Radiotherapy in Patients with Advanced Breast Cancer Treated with Cyclin-Dependent Kinase 4/6 Inhibitors Based on Real-World Data;Pharmaceuticals;2024-07-11

4. Tumor infiltrating lymphocytes density as the chemoresistance and relapse factor for advanced breast cancer patients;MED BALEAR;2024

5. Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series;The Oncologist;2024-06-10